(Posdinemab)Biosimilar Reference Antibody-GS40560

货号：GS40560

Posdinemab is an investigational humanized IgG1 kappa monoclonal antibody developed by Johnson & Johnson. It is designed as a potential disease-modifying therapy for early Alzheimer's disease. The antibody is engineered to specifically target and bind to pathological forms of tau protein. By doing so, it aims to facilitate the clearance of toxic tau aggregates from the brain, potentially slowing or preventing the spread of tau pathology along neuronal networks, which is closely associated with cognitive decline and disease progression in Alzheimer's.